AlloVir Inc. (ALVR)
NASDAQ: ALVR
· Real-Time Price · USD
9.81
0.39 (4.14%)
At close: Mar 18, 2025, 3:59 PM
AlloVir Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 8.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 141K | 3.64M | n/a | 547K | 1.09M | 199K | 426K | 846K | 554K | 44K | 33K | 486K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 8.24M | -3.64M | n/a | -547K | -1.09M | -199K | -426K | -846K | -554K | -44K | -33K | -486K |
Operating Income | -10.35M | -29.11M | -5.72M | -7.77M | -22.84M | -43.84M | -46.96M | -47.3M | -43.23M | -40.44M | -42.95M | -44.62M | -43.19M | -55.8M | -45.5M | -37.66M | -30.86M |
Interest Income | n/a | 1.39M | 1.49M | 1.36M | 1.25M | 1.37M | 1.52M | 1.52M | 1.32M | 898K | 668K | 162K | 148K | 82K | 253K | 475K | 505K |
Pretax Income | n/a | -18.27M | -4.13M | -6.08M | -30.3M | -59.82M | -44.27M | -45.27M | -41.18M | -38.55M | -42.07M | -44.49M | -43.86M | -56.93M | -45.51M | -37.59M | -30.92M |
Net Income | n/a | -18.27M | -4.13M | -6.08M | -30.3M | -59.7M | -44.27M | -45.27M | -41.18M | -38.14M | -42.07M | -44.64M | -43.86M | -57.94M | -45.51M | -37.59M | -30.92M |
Selling & General & Admin | 4.32M | 19.2M | 5.88M | 7.17M | 10.66M | 10.46M | 12.8M | 15.99M | 12.51M | 12.01M | 12.95M | 13.24M | 14.13M | 14.19M | 12.44M | 11.98M | 10.47M |
Research & Development | 6.03M | 320K | -246K | 93K | 12.17M | 33.23M | 34.16M | 31.31M | 30.72M | 27.33M | 30M | 31.38M | 29.07M | 41.6M | 33.06M | 25.68M | 20.39M |
Other Expenses | n/a | 126K | 83K | 512K | n/a | n/a | -3.64M | n/a | -723K | 109K | n/a | n/a | -846K | n/a | n/a | n/a | n/a |
Operating Expenses | 10.35M | 19.65M | 5.72M | 7.77M | 22.84M | 43.7M | 43.32M | 47.3M | 42.51M | 39.45M | 42.95M | 44.62M | 42.35M | 55.8M | 45.5M | 37.66M | 30.86M |
Interest Expense | -1.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 19.65M | 5.72M | 7.77M | 22.84M | 43.84M | 46.96M | 47.3M | 43.23M | 40.43M | 42.95M | 44.62M | 43.19M | 55.8M | 45.5M | 37.66M | 30.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | -99.5K | -126K | -86K | n/a | n/a | -415K | n/a | 150K | n/a | 1.01M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.96M | 4.96M | 4.96M | 4.95M | 4.93M | 4.91M | 4.9M | 4.07M | 4.01M | 4M | 3.65M | 2.77M | 2.75M | 2.72M | 2.71M | 2.68M | 2.67M |
Shares Outstanding (Diluted) | 4.96M | 4.96M | 4.96M | 4.95M | 4.93M | 4.91M | 4.9M | 4.07M | 4.01M | 4M | 3.65M | 2.77M | 2.75M | 2.72M | 2.71M | 2.68M | 2.67M |
EPS (Basic) | n/a | -3.68 | -0.82 | -1.21 | -5.98 | -11.96 | -8.97 | -11.04 | -10.12 | -9.43 | -11.5 | -15.87 | -15.87 | -20.93 | -16.56 | -13.8 | -11.5 |
EPS (Diluted) | n/a | -3.68 | -0.82 | -1.21 | -5.98 | -11.96 | -8.97 | -11.04 | -10.12 | -9.43 | -11.5 | -15.87 | -15.87 | -20.93 | -16.56 | -13.8 | -11.5 |
EBITDA | -10.35M | -19.52M | -5.64M | -6.08M | -22.84M | -43.7M | -46.96M | -47.22M | -43.23M | -40.35M | -42.87M | -44.54M | -42.73M | -55.7M | -45.46M | -37.62M | -30.84M |
EBIT | n/a | -19.52M | -5.64M | -7.26M | -22.84M | -43.84M | -46.96M | -47.3M | -43.23M | -40.43M | -42.95M | -44.62M | -43.19M | -55.8M | -45.5M | -37.66M | -30.86M |
Depreciation & Amortization | n/a | 329.5K | 83K | -512K | 99.5K | 141K | 86K | 85K | 86K | 86K | 199K | 86K | 466K | 94K | 44K | 33K | 18K |